- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04972994
Laparoscopic Colectomies In Management of Colonic Cancers
Surgical Outcomes After Laparoscopic Intracorporeal Versus Extracorporeal Anastomosis for Right and Left Hemicolectomies In Management of Colonic Cancers
Study Overview
Status
Detailed Description
This is clinical trial ,Interventional quasi experiment study to evaluate the surgical outcomes between intracorporeal versus extracorporeal anastomosis in laparoscopic right and left hemicolectomies including post operative pain, hospital stay, leakage from anastomosis, early recurrence, hernias patient satisfaction operative time and more surgical outcomes.
In Egyptian hospitals. Source of data the investigators follow up and medical reports and more . surgical procedures This trial including two groups of patients with right and left cancer colon undergoing Laparoscopic colectomy. First group (A) will be operated as intracorporeal anastomosis while the second group (B) will be operated as extracorporeal anastomosis.
Sample size more than 50 person Statistical analysis plan Statistical Package for the Social Sciences (SPSS) program
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Abdullah AA Abdullah, M.B.B.Ch,M.Sc
- Phone Number: 0114386363 01060105272
- Email: abdallah.attia@med.sohag.edu.eg
Study Contact Backup
- Name: Omar AS AlTabary, professor
- Phone Number: 01001164704
Study Locations
-
-
-
Sohag, Egypt
- Recruiting
- Sohag University Hospital
-
Sub-Investigator:
- Omar AS Al tabary, professor
-
Sub-Investigator:
- Abd El-Aal AS Mahran, Assistant professor
-
Sub-Investigator:
- Ahmed A Aldardeer, Lecturer
-
Sub-Investigator:
- Ahmed Farag, professor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients had to present histologically confirmed cancer( right and left) colon.
- All grades of cancer will be included.
- Cancer at cecum ,appendix, ascending colon, hepatic flexure or at splenic flexure , descending colon and sigmoid colon.
Exclusion Criteria:
- Locally advanced disease with invasion of adjacent important organs.
- Acute bowel obstruction or perforation from cancer.
- Pregnant ladies.
- Rectal cancer and transverse colon cancer.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: laparoscopic intracorporeal anastomosis for right and left hemicolectomies
Surgical outcomes after laparoscopic intracorporeal versus for right and left hemicolectomies in management of colonic cancers
|
laparoscopic intracorporeal versus extracorporeal anastomosis for right and left hemicolectomies in management of colonic cancers
|
|
Active Comparator: laparoscopic extracorporeal anastomosis for right and left hemicolectomies
Surgical outcomes after laparoscopic extracorporeal anastomosis for right and left hemicolectomies in management of colonic cancers
|
laparoscopic intracorporeal versus extracorporeal anastomosis for right and left hemicolectomies in management of colonic cancers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
intraoperative time of surgery
Time Frame: intraoperative time of surgery
|
intraoperative time of surgery by minutes
|
intraoperative time of surgery
|
|
post operative hospital stay
Time Frame: up to 1 year
|
post operative hospital stay by days
|
up to 1 year
|
|
Post operative leakage
Time Frame: 1 year
|
Post operative leakage of anastomosis by follow up ultrasound, Abdominal Xray erect & wound infection
|
1 year
|
|
early recurrence of the cancer
Time Frame: 6 months after surgery
|
early recurrence of the cancer by CT scan
|
6 months after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Omar AS Al tabary, Professor, Sohag University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med206018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.